Lithium-induced hypercalcemia and parathyroid dysfunction.
Rifai
M A
MA
University of Virginia, School of Medicine, Roanoke-Salem Program, USA.
Moles
J K
JK
Harrington
D P
DP
D018692:Antimanic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D002118:Calcium / Q000097:blood; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000139:chemically induced*; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000139:chemically induced*; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*
D018692:Antimanic Agents; D010281:Parathyroid Hormone; D016651:Lithium Carbonate; D002118:Calcium